Table 2

Mean UTC echo-types of the participants Achilles tendon mid-portion and the AoMD at baseline, and during follow-up at 26 weeks

Echo-typeMid-portion
Total group (n=40)
Mean±SD (min-max)
AoMD
Total group (n=40)
Mean±SD (min-max)
BaselineFollow-upBaselineFollow-up
I (%)48.3±11.9
(27.3–75.2)
51.4±11.3
(28.8–75.6)
37.1±11.9
(14.7–64.8)
40.7±11.8
(17.0–65.1)
II (%)19.4±4.6
(10.5–32.9)
21,0±4.5
(10.5–32.1)
22.2±7.4
(12.2–42.9)
22.6±7.1
(9.8–39.9)
III (%)19.1±8.7
(2.6–35.5)
16.7±8.7
(1.9–37.8)
26.6±11.9
(1.5–49.7)
23.7±11.5
(2.8–49.5)
IV (%)13.1±6.6
(1.9–29.2)
10.8±5.3
(1.4–25.6)
13.8±6.7
(0.4–24.3)
12.4±5.9
(0.8–27.3)
Total100%100%100%100%
I+II (%)67.8±14.4
(40.8–95.3)
72.4±13.2
(42.5–96.6)
59.2±17.0
(30.0–98.1)
63.3±16.4
(27.4–96.5)
III+IV (%)32.2±14.4
(4.7–59.3)
27.6±13.2
(3.3–57.5)
40.4±17.5
(1.9–70.0)
36.2±16.4
(3.6–72.5)
Total100%100%100%100%
  • Echo-types I, II, III and IV are expressed as a percentage of the analysed Achilles tendon volume. Combined, the echo-types I+II represent aligned fibrillar structure, and the echo-types III+IV disorganised tendon structure.

  • AoMD, area of maximum degeneration (one slide in the Achilles tendon mid-portion with the lowest representation of echo-type I); max, maximum; min, minimum; n, number; SD, standard deviation; UTC, ultrasound tissue characterisation.